Related references
Note: Only part of the references are listed.Hyperammonemia alters the modulation by different neurosteroids of the glutamate-nitric oxide-cyclic GMP pathway through NMDA-GABAA- or sigma receptors in cerebellum in vivo
Alba Gonzalez-Usano et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests
Vicente Felipo et al.
HEPATOLOGY (2012)
p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts
Ana Agusti et al.
GUT (2011)
Hyperammonemia Induces Neuroinflammation That Contributes to Cognitive Impairment in Rats With Hepatic Encephalopathy
Regina Rodrigo et al.
GASTROENTEROLOGY (2010)
Hyperammonemia Increases GABAergic Tone in the Cerebellum but Decreases It in the Rat Cortex
Omar Cauli et al.
GASTROENTEROLOGY (2009)
IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic Encephalopathy
Carmina Montoliu et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Experimental models of hepatic encephalopathy: ISHEN guidelines
Roger F. Butterworth et al.
LIVER INTERNATIONAL (2009)
Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy
Omar Cauli et al.
METABOLIC BRAIN DISEASE (2009)
The neurosteroid system: Implication in the pathophysiology of hepatic encephalopathy
Samir Ahboucha et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
Ming-Kai Chen et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Imaging brain inflammation with [11C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats
Santiago Rojas et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy
Samir Ahboucha et al.
METABOLIC BRAIN DISEASE (2007)
Translocator protein (18 kDa) is involved in the regulation of reactive gliosis
Sergio Veiga et al.
GLIA (2007)
Inflammation and hepatic encephalopathy: Ibuprofen restores learning ability in rats with portacaval shunts
Omar Cauli et al.
HEPATOLOGY (2007)
Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor
Jun Maeda et al.
BRAIN RESEARCH (2007)
Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients
Carmina Montoliu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma
Samir Ahboucha et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination
Ming-Kai Chen et al.
TOXICOLOGICAL SCIENCES (2006)
In vivo imaging of cerebral peripheral benzodiazepine binding sites'' in patients with hepatic encephalopathy
A Cagnin et al.
GUT (2006)
Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity
S Veiga et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Down-regulation of astroglial proteins in the rat cerebellum after portacaval anastomosis
I Suárez et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure
M Odeh et al.
ANNALS OF MEDICINE (2005)
Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis
EG Jorda et al.
APOPTOSIS (2005)
Serum levels of tumor necrosis factor-α correlate with severity of hepatic encephalopathy due to chronic liver failure
M Odeh et al.
LIVER INTERNATIONAL (2004)
Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis
DL Shawcross et al.
JOURNAL OF HEPATOLOGY (2004)
Characteristics of minimal hepatic encephalopathy
P Amodio et al.
METABOLIC BRAIN DISEASE (2004)
In vivo and in vitro peripheral-type benzodiazepine receptor polymerization:: Functional significance in drug ligand and cholesterol binding
F Delavoie et al.
BIOCHEMISTRY (2003)
Methamphetamine-induced deficits of brain monoaminergic neuronal markers: Distal axotomy or neuronal plasticity
TR Guilarte et al.
NEUROSCIENCE (2003)
Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells
AR Jayakumar et al.
JOURNAL OF NEUROCHEMISTRY (2002)
The peripheral-type benzodiazepine (omega 3) receptor in hyperammonemic disorders
P Desjardins et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998
P Ferenci et al.
HEPATOLOGY (2002)
Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity
AC Kuhlmann et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
